Global Immuno-oncology Diagnosis Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Immuno-oncology Diagnosis Industry Forecast” looks at past sales and reviews total world Immuno-oncology Diagnosis sales in 2022, providing a comprehensive analysis by region and market sector of projected Immuno-oncology Diagnosis sales for 2023 through 2029. With Immuno-oncology Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immuno-oncology Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Immuno-oncology Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immuno-oncology Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immuno-oncology Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immuno-oncology Diagnosis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immuno-oncology Diagnosis.
The global Immuno-oncology Diagnosis market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Immuno-oncology Diagnosis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Immuno-oncology Diagnosis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Immuno-oncology Diagnosis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Immuno-oncology Diagnosis players cover 10x Genomics, Abbott Laboratories, Abcam, Adaptive Biotechnologies, Aethlon Medical, Agena Bioscience, Angle plc, Apocell and ARUP Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-oncology Diagnosis market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Immuno-oncology Diagnosis Industry Forecast” looks at past sales and reviews total world Immuno-oncology Diagnosis sales in 2022, providing a comprehensive analysis by region and market sector of projected Immuno-oncology Diagnosis sales for 2023 through 2029. With Immuno-oncology Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immuno-oncology Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Immuno-oncology Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immuno-oncology Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immuno-oncology Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immuno-oncology Diagnosis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immuno-oncology Diagnosis.
The global Immuno-oncology Diagnosis market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Immuno-oncology Diagnosis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Immuno-oncology Diagnosis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Immuno-oncology Diagnosis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Immuno-oncology Diagnosis players cover 10x Genomics, Abbott Laboratories, Abcam, Adaptive Biotechnologies, Aethlon Medical, Agena Bioscience, Angle plc, Apocell and ARUP Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-oncology Diagnosis market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- PCR
- NGS
- Immunoassay
- Research
- Diagnostics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- 10x Genomics
- Abbott Laboratories
- Abcam
- Adaptive Biotechnologies
- Aethlon Medical
- Agena Bioscience
- Angle plc
- Apocell
- ARUP Laboratories
- Beckman Coulter
- Becton Dickinson
- Bioarray Genetics
- BioCartis
- Biocept
- Biodesix Inc
- BioFluidica
- BioGenex 40 bioM?rieux
- Bio-Rad
- Bio-Techne
- Bristol-Myers Squibb
- Cancer Genetics
- Caris Molecular Diagnostics
- CellMax Life
- Charles River Laboratories
- Chronix Biomedical
- Circulogene
- Clearbridge BioMedics
- Clinical Genomics
- Pfizer
- Promega
- Protagen Diagnostics
- Qiagen
- Quanterix
- Rarecells SAS
- Roche Diagnostics
- Siemens
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immuno-oncology Diagnosis Market Size 2018-2029
2.1.2 Immuno-oncology Diagnosis Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Immuno-oncology Diagnosis Segment by Type
2.2.1 PCR
2.2.2 NGS
2.2.3 Immunoassay
2.3 Immuno-oncology Diagnosis Market Size by Type
2.3.1 Immuno-oncology Diagnosis Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
2.4 Immuno-oncology Diagnosis Segment by Application
2.4.1 Research
2.4.2 Diagnostics
2.5 Immuno-oncology Diagnosis Market Size by Application
2.5.1 Immuno-oncology Diagnosis Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
3 IMMUNO-ONCOLOGY DIAGNOSIS MARKET SIZE BY PLAYER
3.1 Immuno-oncology Diagnosis Market Size Market Share by Players
3.1.1 Global Immuno-oncology Diagnosis Revenue by Players (2018-2023)
3.1.2 Global Immuno-oncology Diagnosis Revenue Market Share by Players (2018-2023)
3.2 Global Immuno-oncology Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNO-ONCOLOGY DIAGNOSIS BY REGIONS
4.1 Immuno-oncology Diagnosis Market Size by Regions (2018-2023)
4.2 Americas Immuno-oncology Diagnosis Market Size Growth (2018-2023)
4.3 APAC Immuno-oncology Diagnosis Market Size Growth (2018-2023)
4.4 Europe Immuno-oncology Diagnosis Market Size Growth (2018-2023)
4.5 Middle East & Africa Immuno-oncology Diagnosis Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Immuno-oncology Diagnosis Market Size by Country (2018-2023)
5.2 Americas Immuno-oncology Diagnosis Market Size by Type (2018-2023)
5.3 Americas Immuno-oncology Diagnosis Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immuno-oncology Diagnosis Market Size by Region (2018-2023)
6.2 APAC Immuno-oncology Diagnosis Market Size by Type (2018-2023)
6.3 APAC Immuno-oncology Diagnosis Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immuno-oncology Diagnosis by Country (2018-2023)
7.2 Europe Immuno-oncology Diagnosis Market Size by Type (2018-2023)
7.3 Europe Immuno-oncology Diagnosis Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immuno-oncology Diagnosis by Region (2018-2023)
8.2 Middle East & Africa Immuno-oncology Diagnosis Market Size by Type (2018-2023)
8.3 Middle East & Africa Immuno-oncology Diagnosis Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNO-ONCOLOGY DIAGNOSIS MARKET FORECAST
10.1 Global Immuno-oncology Diagnosis Forecast by Regions (2024-2029)
10.1.1 Global Immuno-oncology Diagnosis Forecast by Regions (2024-2029)
10.1.2 Americas Immuno-oncology Diagnosis Forecast
10.1.3 APAC Immuno-oncology Diagnosis Forecast
10.1.4 Europe Immuno-oncology Diagnosis Forecast
10.1.5 Middle East & Africa Immuno-oncology Diagnosis Forecast
10.2 Americas Immuno-oncology Diagnosis Forecast by Country (2024-2029)
10.2.1 United States Immuno-oncology Diagnosis Market Forecast
10.2.2 Canada Immuno-oncology Diagnosis Market Forecast
10.2.3 Mexico Immuno-oncology Diagnosis Market Forecast
10.2.4 Brazil Immuno-oncology Diagnosis Market Forecast
10.3 APAC Immuno-oncology Diagnosis Forecast by Region (2024-2029)
10.3.1 China Immuno-oncology Diagnosis Market Forecast
10.3.2 Japan Immuno-oncology Diagnosis Market Forecast
10.3.3 Korea Immuno-oncology Diagnosis Market Forecast
10.3.4 Southeast Asia Immuno-oncology Diagnosis Market Forecast
10.3.5 India Immuno-oncology Diagnosis Market Forecast
10.3.6 Australia Immuno-oncology Diagnosis Market Forecast
10.4 Europe Immuno-oncology Diagnosis Forecast by Country (2024-2029)
10.4.1 Germany Immuno-oncology Diagnosis Market Forecast
10.4.2 France Immuno-oncology Diagnosis Market Forecast
10.4.3 UK Immuno-oncology Diagnosis Market Forecast
10.4.4 Italy Immuno-oncology Diagnosis Market Forecast
10.4.5 Russia Immuno-oncology Diagnosis Market Forecast
10.5 Middle East & Africa Immuno-oncology Diagnosis Forecast by Region (2024-2029)
10.5.1 Egypt Immuno-oncology Diagnosis Market Forecast
10.5.2 South Africa Immuno-oncology Diagnosis Market Forecast
10.5.3 Israel Immuno-oncology Diagnosis Market Forecast
10.5.4 Turkey Immuno-oncology Diagnosis Market Forecast
10.5.5 GCC Countries Immuno-oncology Diagnosis Market Forecast
10.6 Global Immuno-oncology Diagnosis Forecast by Type (2024-2029)
10.7 Global Immuno-oncology Diagnosis Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 10x Genomics
11.1.1 10x Genomics Company Information
11.1.2 10x Genomics Immuno-oncology Diagnosis Product Offered
11.1.3 10x Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 10x Genomics Main Business Overview
11.1.5 10x Genomics Latest Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Immuno-oncology Diagnosis Product Offered
11.2.3 Abbott Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Abbott Laboratories Main Business Overview
11.2.5 Abbott Laboratories Latest Developments
11.3 Abcam
11.3.1 Abcam Company Information
11.3.2 Abcam Immuno-oncology Diagnosis Product Offered
11.3.3 Abcam Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Abcam Main Business Overview
11.3.5 Abcam Latest Developments
11.4 Adaptive Biotechnologies
11.4.1 Adaptive Biotechnologies Company Information
11.4.2 Adaptive Biotechnologies Immuno-oncology Diagnosis Product Offered
11.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Adaptive Biotechnologies Main Business Overview
11.4.5 Adaptive Biotechnologies Latest Developments
11.5 Aethlon Medical
11.5.1 Aethlon Medical Company Information
11.5.2 Aethlon Medical Immuno-oncology Diagnosis Product Offered
11.5.3 Aethlon Medical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Aethlon Medical Main Business Overview
11.5.5 Aethlon Medical Latest Developments
11.6 Agena Bioscience
11.6.1 Agena Bioscience Company Information
11.6.2 Agena Bioscience Immuno-oncology Diagnosis Product Offered
11.6.3 Agena Bioscience Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Agena Bioscience Main Business Overview
11.6.5 Agena Bioscience Latest Developments
11.7 Angle plc
11.7.1 Angle plc Company Information
11.7.2 Angle plc Immuno-oncology Diagnosis Product Offered
11.7.3 Angle plc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Angle plc Main Business Overview
11.7.5 Angle plc Latest Developments
11.8 Apocell
11.8.1 Apocell Company Information
11.8.2 Apocell Immuno-oncology Diagnosis Product Offered
11.8.3 Apocell Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Apocell Main Business Overview
11.8.5 Apocell Latest Developments
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Information
11.9.2 ARUP Laboratories Immuno-oncology Diagnosis Product Offered
11.9.3 ARUP Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 ARUP Laboratories Main Business Overview
11.9.5 ARUP Laboratories Latest Developments
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Information
11.10.2 Beckman Coulter Immuno-oncology Diagnosis Product Offered
11.10.3 Beckman Coulter Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Beckman Coulter Main Business Overview
11.10.5 Beckman Coulter Latest Developments
11.11 Becton Dickinson
11.11.1 Becton Dickinson Company Information
11.11.2 Becton Dickinson Immuno-oncology Diagnosis Product Offered
11.11.3 Becton Dickinson Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Becton Dickinson Main Business Overview
11.11.5 Becton Dickinson Latest Developments
11.12 Bioarray Genetics
11.12.1 Bioarray Genetics Company Information
11.12.2 Bioarray Genetics Immuno-oncology Diagnosis Product Offered
11.12.3 Bioarray Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Bioarray Genetics Main Business Overview
11.12.5 Bioarray Genetics Latest Developments
11.13 BioCartis
11.13.1 BioCartis Company Information
11.13.2 BioCartis Immuno-oncology Diagnosis Product Offered
11.13.3 BioCartis Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 BioCartis Main Business Overview
11.13.5 BioCartis Latest Developments
11.14 Biocept
11.14.1 Biocept Company Information
11.14.2 Biocept Immuno-oncology Diagnosis Product Offered
11.14.3 Biocept Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Biocept Main Business Overview
11.14.5 Biocept Latest Developments
11.15 Biodesix Inc
11.15.1 Biodesix Inc Company Information
11.15.2 Biodesix Inc Immuno-oncology Diagnosis Product Offered
11.15.3 Biodesix Inc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Biodesix Inc Main Business Overview
11.15.5 Biodesix Inc Latest Developments
11.16 BioFluidica
11.16.1 BioFluidica Company Information
11.16.2 BioFluidica Immuno-oncology Diagnosis Product Offered
11.16.3 BioFluidica Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 BioFluidica Main Business Overview
11.16.5 BioFluidica Latest Developments
11.17 BioGenex 40 bioM?rieux
11.17.1 BioGenex 40 bioM?rieux Company Information
11.17.2 BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Product Offered
11.17.3 BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 BioGenex 40 bioM?rieux Main Business Overview
11.17.5 BioGenex 40 bioM?rieux Latest Developments
11.18 Bio-Rad
11.18.1 Bio-Rad Company Information
11.18.2 Bio-Rad Immuno-oncology Diagnosis Product Offered
11.18.3 Bio-Rad Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Bio-Rad Main Business Overview
11.18.5 Bio-Rad Latest Developments
11.19 Bio-Techne
11.19.1 Bio-Techne Company Information
11.19.2 Bio-Techne Immuno-oncology Diagnosis Product Offered
11.19.3 Bio-Techne Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Bio-Techne Main Business Overview
11.19.5 Bio-Techne Latest Developments
11.20 Bristol-Myers Squibb
11.20.1 Bristol-Myers Squibb Company Information
11.20.2 Bristol-Myers Squibb Immuno-oncology Diagnosis Product Offered
11.20.3 Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Bristol-Myers Squibb Main Business Overview
11.20.5 Bristol-Myers Squibb Latest Developments
11.21 Cancer Genetics
11.21.1 Cancer Genetics Company Information
11.21.2 Cancer Genetics Immuno-oncology Diagnosis Product Offered
11.21.3 Cancer Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Cancer Genetics Main Business Overview
11.21.5 Cancer Genetics Latest Developments
11.22 Caris Molecular Diagnostics
11.22.1 Caris Molecular Diagnostics Company Information
11.22.2 Caris Molecular Diagnostics Immuno-oncology Diagnosis Product Offered
11.22.3 Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Caris Molecular Diagnostics Main Business Overview
11.22.5 Caris Molecular Diagnostics Latest Developments
11.23 CellMax Life
11.23.1 CellMax Life Company Information
11.23.2 CellMax Life Immuno-oncology Diagnosis Product Offered
11.23.3 CellMax Life Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 CellMax Life Main Business Overview
11.23.5 CellMax Life Latest Developments
11.24 Charles River Laboratories
11.24.1 Charles River Laboratories Company Information
11.24.2 Charles River Laboratories Immuno-oncology Diagnosis Product Offered
11.24.3 Charles River Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Charles River Laboratories Main Business Overview
11.24.5 Charles River Laboratories Latest Developments
11.25 Chronix Biomedical
11.25.1 Chronix Biomedical Company Information
11.25.2 Chronix Biomedical Immuno-oncology Diagnosis Product Offered
11.25.3 Chronix Biomedical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Chronix Biomedical Main Business Overview
11.25.5 Chronix Biomedical Latest Developments
11.26 Circulogene
11.26.1 Circulogene Company Information
11.26.2 Circulogene Immuno-oncology Diagnosis Product Offered
11.26.3 Circulogene Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Circulogene Main Business Overview
11.26.5 Circulogene Latest Developments
11.27 Clearbridge BioMedics
11.27.1 Clearbridge BioMedics Company Information
11.27.2 Clearbridge BioMedics Immuno-oncology Diagnosis Product Offered
11.27.3 Clearbridge BioMedics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.27.4 Clearbridge BioMedics Main Business Overview
11.27.5 Clearbridge BioMedics Latest Developments
11.28 Clinical Genomics
11.28.1 Clinical Genomics Company Information
11.28.2 Clinical Genomics Immuno-oncology Diagnosis Product Offered
11.28.3 Clinical Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.28.4 Clinical Genomics Main Business Overview
11.28.5 Clinical Genomics Latest Developments
11.29 Pfizer
11.29.1 Pfizer Company Information
11.29.2 Pfizer Immuno-oncology Diagnosis Product Offered
11.29.3 Pfizer Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.29.4 Pfizer Main Business Overview
11.29.5 Pfizer Latest Developments
11.30 Promega
11.30.1 Promega Company Information
11.30.2 Promega Immuno-oncology Diagnosis Product Offered
11.30.3 Promega Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.30.4 Promega Main Business Overview
11.30.5 Promega Latest Developments
11.31 Protagen Diagnostics
11.31.1 Protagen Diagnostics Company Information
11.31.2 Protagen Diagnostics Immuno-oncology Diagnosis Product Offered
11.31.3 Protagen Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.31.4 Protagen Diagnostics Main Business Overview
11.31.5 Protagen Diagnostics Latest Developments
11.32 Qiagen
11.32.1 Qiagen Company Information
11.32.2 Qiagen Immuno-oncology Diagnosis Product Offered
11.32.3 Qiagen Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.32.4 Qiagen Main Business Overview
11.32.5 Qiagen Latest Developments
11.33 Quanterix
11.33.1 Quanterix Company Information
11.33.2 Quanterix Immuno-oncology Diagnosis Product Offered
11.33.3 Quanterix Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.33.4 Quanterix Main Business Overview
11.33.5 Quanterix Latest Developments
11.34 Rarecells SAS
11.34.1 Rarecells SAS Company Information
11.34.2 Rarecells SAS Immuno-oncology Diagnosis Product Offered
11.34.3 Rarecells SAS Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.34.4 Rarecells SAS Main Business Overview
11.34.5 Rarecells SAS Latest Developments
11.35 Roche Diagnostics
11.35.1 Roche Diagnostics Company Information
11.35.2 Roche Diagnostics Immuno-oncology Diagnosis Product Offered
11.35.3 Roche Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.35.4 Roche Diagnostics Main Business Overview
11.35.5 Roche Diagnostics Latest Developments
11.36 Siemens
11.36.1 Siemens Company Information
11.36.2 Siemens Immuno-oncology Diagnosis Product Offered
11.36.3 Siemens Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.36.4 Siemens Main Business Overview
11.36.5 Siemens Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immuno-oncology Diagnosis Market Size 2018-2029
2.1.2 Immuno-oncology Diagnosis Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Immuno-oncology Diagnosis Segment by Type
2.2.1 PCR
2.2.2 NGS
2.2.3 Immunoassay
2.3 Immuno-oncology Diagnosis Market Size by Type
2.3.1 Immuno-oncology Diagnosis Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
2.4 Immuno-oncology Diagnosis Segment by Application
2.4.1 Research
2.4.2 Diagnostics
2.5 Immuno-oncology Diagnosis Market Size by Application
2.5.1 Immuno-oncology Diagnosis Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
3 IMMUNO-ONCOLOGY DIAGNOSIS MARKET SIZE BY PLAYER
3.1 Immuno-oncology Diagnosis Market Size Market Share by Players
3.1.1 Global Immuno-oncology Diagnosis Revenue by Players (2018-2023)
3.1.2 Global Immuno-oncology Diagnosis Revenue Market Share by Players (2018-2023)
3.2 Global Immuno-oncology Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNO-ONCOLOGY DIAGNOSIS BY REGIONS
4.1 Immuno-oncology Diagnosis Market Size by Regions (2018-2023)
4.2 Americas Immuno-oncology Diagnosis Market Size Growth (2018-2023)
4.3 APAC Immuno-oncology Diagnosis Market Size Growth (2018-2023)
4.4 Europe Immuno-oncology Diagnosis Market Size Growth (2018-2023)
4.5 Middle East & Africa Immuno-oncology Diagnosis Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Immuno-oncology Diagnosis Market Size by Country (2018-2023)
5.2 Americas Immuno-oncology Diagnosis Market Size by Type (2018-2023)
5.3 Americas Immuno-oncology Diagnosis Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immuno-oncology Diagnosis Market Size by Region (2018-2023)
6.2 APAC Immuno-oncology Diagnosis Market Size by Type (2018-2023)
6.3 APAC Immuno-oncology Diagnosis Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immuno-oncology Diagnosis by Country (2018-2023)
7.2 Europe Immuno-oncology Diagnosis Market Size by Type (2018-2023)
7.3 Europe Immuno-oncology Diagnosis Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immuno-oncology Diagnosis by Region (2018-2023)
8.2 Middle East & Africa Immuno-oncology Diagnosis Market Size by Type (2018-2023)
8.3 Middle East & Africa Immuno-oncology Diagnosis Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNO-ONCOLOGY DIAGNOSIS MARKET FORECAST
10.1 Global Immuno-oncology Diagnosis Forecast by Regions (2024-2029)
10.1.1 Global Immuno-oncology Diagnosis Forecast by Regions (2024-2029)
10.1.2 Americas Immuno-oncology Diagnosis Forecast
10.1.3 APAC Immuno-oncology Diagnosis Forecast
10.1.4 Europe Immuno-oncology Diagnosis Forecast
10.1.5 Middle East & Africa Immuno-oncology Diagnosis Forecast
10.2 Americas Immuno-oncology Diagnosis Forecast by Country (2024-2029)
10.2.1 United States Immuno-oncology Diagnosis Market Forecast
10.2.2 Canada Immuno-oncology Diagnosis Market Forecast
10.2.3 Mexico Immuno-oncology Diagnosis Market Forecast
10.2.4 Brazil Immuno-oncology Diagnosis Market Forecast
10.3 APAC Immuno-oncology Diagnosis Forecast by Region (2024-2029)
10.3.1 China Immuno-oncology Diagnosis Market Forecast
10.3.2 Japan Immuno-oncology Diagnosis Market Forecast
10.3.3 Korea Immuno-oncology Diagnosis Market Forecast
10.3.4 Southeast Asia Immuno-oncology Diagnosis Market Forecast
10.3.5 India Immuno-oncology Diagnosis Market Forecast
10.3.6 Australia Immuno-oncology Diagnosis Market Forecast
10.4 Europe Immuno-oncology Diagnosis Forecast by Country (2024-2029)
10.4.1 Germany Immuno-oncology Diagnosis Market Forecast
10.4.2 France Immuno-oncology Diagnosis Market Forecast
10.4.3 UK Immuno-oncology Diagnosis Market Forecast
10.4.4 Italy Immuno-oncology Diagnosis Market Forecast
10.4.5 Russia Immuno-oncology Diagnosis Market Forecast
10.5 Middle East & Africa Immuno-oncology Diagnosis Forecast by Region (2024-2029)
10.5.1 Egypt Immuno-oncology Diagnosis Market Forecast
10.5.2 South Africa Immuno-oncology Diagnosis Market Forecast
10.5.3 Israel Immuno-oncology Diagnosis Market Forecast
10.5.4 Turkey Immuno-oncology Diagnosis Market Forecast
10.5.5 GCC Countries Immuno-oncology Diagnosis Market Forecast
10.6 Global Immuno-oncology Diagnosis Forecast by Type (2024-2029)
10.7 Global Immuno-oncology Diagnosis Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 10x Genomics
11.1.1 10x Genomics Company Information
11.1.2 10x Genomics Immuno-oncology Diagnosis Product Offered
11.1.3 10x Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 10x Genomics Main Business Overview
11.1.5 10x Genomics Latest Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Immuno-oncology Diagnosis Product Offered
11.2.3 Abbott Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Abbott Laboratories Main Business Overview
11.2.5 Abbott Laboratories Latest Developments
11.3 Abcam
11.3.1 Abcam Company Information
11.3.2 Abcam Immuno-oncology Diagnosis Product Offered
11.3.3 Abcam Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Abcam Main Business Overview
11.3.5 Abcam Latest Developments
11.4 Adaptive Biotechnologies
11.4.1 Adaptive Biotechnologies Company Information
11.4.2 Adaptive Biotechnologies Immuno-oncology Diagnosis Product Offered
11.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Adaptive Biotechnologies Main Business Overview
11.4.5 Adaptive Biotechnologies Latest Developments
11.5 Aethlon Medical
11.5.1 Aethlon Medical Company Information
11.5.2 Aethlon Medical Immuno-oncology Diagnosis Product Offered
11.5.3 Aethlon Medical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Aethlon Medical Main Business Overview
11.5.5 Aethlon Medical Latest Developments
11.6 Agena Bioscience
11.6.1 Agena Bioscience Company Information
11.6.2 Agena Bioscience Immuno-oncology Diagnosis Product Offered
11.6.3 Agena Bioscience Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Agena Bioscience Main Business Overview
11.6.5 Agena Bioscience Latest Developments
11.7 Angle plc
11.7.1 Angle plc Company Information
11.7.2 Angle plc Immuno-oncology Diagnosis Product Offered
11.7.3 Angle plc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Angle plc Main Business Overview
11.7.5 Angle plc Latest Developments
11.8 Apocell
11.8.1 Apocell Company Information
11.8.2 Apocell Immuno-oncology Diagnosis Product Offered
11.8.3 Apocell Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Apocell Main Business Overview
11.8.5 Apocell Latest Developments
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Information
11.9.2 ARUP Laboratories Immuno-oncology Diagnosis Product Offered
11.9.3 ARUP Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 ARUP Laboratories Main Business Overview
11.9.5 ARUP Laboratories Latest Developments
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Information
11.10.2 Beckman Coulter Immuno-oncology Diagnosis Product Offered
11.10.3 Beckman Coulter Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Beckman Coulter Main Business Overview
11.10.5 Beckman Coulter Latest Developments
11.11 Becton Dickinson
11.11.1 Becton Dickinson Company Information
11.11.2 Becton Dickinson Immuno-oncology Diagnosis Product Offered
11.11.3 Becton Dickinson Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Becton Dickinson Main Business Overview
11.11.5 Becton Dickinson Latest Developments
11.12 Bioarray Genetics
11.12.1 Bioarray Genetics Company Information
11.12.2 Bioarray Genetics Immuno-oncology Diagnosis Product Offered
11.12.3 Bioarray Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Bioarray Genetics Main Business Overview
11.12.5 Bioarray Genetics Latest Developments
11.13 BioCartis
11.13.1 BioCartis Company Information
11.13.2 BioCartis Immuno-oncology Diagnosis Product Offered
11.13.3 BioCartis Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 BioCartis Main Business Overview
11.13.5 BioCartis Latest Developments
11.14 Biocept
11.14.1 Biocept Company Information
11.14.2 Biocept Immuno-oncology Diagnosis Product Offered
11.14.3 Biocept Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Biocept Main Business Overview
11.14.5 Biocept Latest Developments
11.15 Biodesix Inc
11.15.1 Biodesix Inc Company Information
11.15.2 Biodesix Inc Immuno-oncology Diagnosis Product Offered
11.15.3 Biodesix Inc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Biodesix Inc Main Business Overview
11.15.5 Biodesix Inc Latest Developments
11.16 BioFluidica
11.16.1 BioFluidica Company Information
11.16.2 BioFluidica Immuno-oncology Diagnosis Product Offered
11.16.3 BioFluidica Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 BioFluidica Main Business Overview
11.16.5 BioFluidica Latest Developments
11.17 BioGenex 40 bioM?rieux
11.17.1 BioGenex 40 bioM?rieux Company Information
11.17.2 BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Product Offered
11.17.3 BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 BioGenex 40 bioM?rieux Main Business Overview
11.17.5 BioGenex 40 bioM?rieux Latest Developments
11.18 Bio-Rad
11.18.1 Bio-Rad Company Information
11.18.2 Bio-Rad Immuno-oncology Diagnosis Product Offered
11.18.3 Bio-Rad Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Bio-Rad Main Business Overview
11.18.5 Bio-Rad Latest Developments
11.19 Bio-Techne
11.19.1 Bio-Techne Company Information
11.19.2 Bio-Techne Immuno-oncology Diagnosis Product Offered
11.19.3 Bio-Techne Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Bio-Techne Main Business Overview
11.19.5 Bio-Techne Latest Developments
11.20 Bristol-Myers Squibb
11.20.1 Bristol-Myers Squibb Company Information
11.20.2 Bristol-Myers Squibb Immuno-oncology Diagnosis Product Offered
11.20.3 Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Bristol-Myers Squibb Main Business Overview
11.20.5 Bristol-Myers Squibb Latest Developments
11.21 Cancer Genetics
11.21.1 Cancer Genetics Company Information
11.21.2 Cancer Genetics Immuno-oncology Diagnosis Product Offered
11.21.3 Cancer Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Cancer Genetics Main Business Overview
11.21.5 Cancer Genetics Latest Developments
11.22 Caris Molecular Diagnostics
11.22.1 Caris Molecular Diagnostics Company Information
11.22.2 Caris Molecular Diagnostics Immuno-oncology Diagnosis Product Offered
11.22.3 Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Caris Molecular Diagnostics Main Business Overview
11.22.5 Caris Molecular Diagnostics Latest Developments
11.23 CellMax Life
11.23.1 CellMax Life Company Information
11.23.2 CellMax Life Immuno-oncology Diagnosis Product Offered
11.23.3 CellMax Life Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 CellMax Life Main Business Overview
11.23.5 CellMax Life Latest Developments
11.24 Charles River Laboratories
11.24.1 Charles River Laboratories Company Information
11.24.2 Charles River Laboratories Immuno-oncology Diagnosis Product Offered
11.24.3 Charles River Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Charles River Laboratories Main Business Overview
11.24.5 Charles River Laboratories Latest Developments
11.25 Chronix Biomedical
11.25.1 Chronix Biomedical Company Information
11.25.2 Chronix Biomedical Immuno-oncology Diagnosis Product Offered
11.25.3 Chronix Biomedical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Chronix Biomedical Main Business Overview
11.25.5 Chronix Biomedical Latest Developments
11.26 Circulogene
11.26.1 Circulogene Company Information
11.26.2 Circulogene Immuno-oncology Diagnosis Product Offered
11.26.3 Circulogene Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Circulogene Main Business Overview
11.26.5 Circulogene Latest Developments
11.27 Clearbridge BioMedics
11.27.1 Clearbridge BioMedics Company Information
11.27.2 Clearbridge BioMedics Immuno-oncology Diagnosis Product Offered
11.27.3 Clearbridge BioMedics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.27.4 Clearbridge BioMedics Main Business Overview
11.27.5 Clearbridge BioMedics Latest Developments
11.28 Clinical Genomics
11.28.1 Clinical Genomics Company Information
11.28.2 Clinical Genomics Immuno-oncology Diagnosis Product Offered
11.28.3 Clinical Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.28.4 Clinical Genomics Main Business Overview
11.28.5 Clinical Genomics Latest Developments
11.29 Pfizer
11.29.1 Pfizer Company Information
11.29.2 Pfizer Immuno-oncology Diagnosis Product Offered
11.29.3 Pfizer Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.29.4 Pfizer Main Business Overview
11.29.5 Pfizer Latest Developments
11.30 Promega
11.30.1 Promega Company Information
11.30.2 Promega Immuno-oncology Diagnosis Product Offered
11.30.3 Promega Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.30.4 Promega Main Business Overview
11.30.5 Promega Latest Developments
11.31 Protagen Diagnostics
11.31.1 Protagen Diagnostics Company Information
11.31.2 Protagen Diagnostics Immuno-oncology Diagnosis Product Offered
11.31.3 Protagen Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.31.4 Protagen Diagnostics Main Business Overview
11.31.5 Protagen Diagnostics Latest Developments
11.32 Qiagen
11.32.1 Qiagen Company Information
11.32.2 Qiagen Immuno-oncology Diagnosis Product Offered
11.32.3 Qiagen Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.32.4 Qiagen Main Business Overview
11.32.5 Qiagen Latest Developments
11.33 Quanterix
11.33.1 Quanterix Company Information
11.33.2 Quanterix Immuno-oncology Diagnosis Product Offered
11.33.3 Quanterix Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.33.4 Quanterix Main Business Overview
11.33.5 Quanterix Latest Developments
11.34 Rarecells SAS
11.34.1 Rarecells SAS Company Information
11.34.2 Rarecells SAS Immuno-oncology Diagnosis Product Offered
11.34.3 Rarecells SAS Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.34.4 Rarecells SAS Main Business Overview
11.34.5 Rarecells SAS Latest Developments
11.35 Roche Diagnostics
11.35.1 Roche Diagnostics Company Information
11.35.2 Roche Diagnostics Immuno-oncology Diagnosis Product Offered
11.35.3 Roche Diagnostics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.35.4 Roche Diagnostics Main Business Overview
11.35.5 Roche Diagnostics Latest Developments
11.36 Siemens
11.36.1 Siemens Company Information
11.36.2 Siemens Immuno-oncology Diagnosis Product Offered
11.36.3 Siemens Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2018-2023)
11.36.4 Siemens Main Business Overview
11.36.5 Siemens Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immuno-oncology Diagnosis Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of PCR
Table 3. Major Players of NGS
Table 4. Major Players of Immunoassay
Table 5. Immuno-oncology Diagnosis Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Immuno-oncology Diagnosis Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Table 8. Immuno-oncology Diagnosis Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Immuno-oncology Diagnosis Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Table 11. Global Immuno-oncology Diagnosis Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Immuno-oncology Diagnosis Revenue Market Share by Player (2018-2023)
Table 13. Immuno-oncology Diagnosis Key Players Head office and Products Offered
Table 14. Immuno-oncology Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Immuno-oncology Diagnosis Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Immuno-oncology Diagnosis Market Size Market Share by Regions (2018-2023)
Table 19. Global Immuno-oncology Diagnosis Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Immuno-oncology Diagnosis Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Immuno-oncology Diagnosis Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Immuno-oncology Diagnosis Market Size Market Share by Country (2018-2023)
Table 23. Americas Immuno-oncology Diagnosis Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Table 25. Americas Immuno-oncology Diagnosis Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Table 27. APAC Immuno-oncology Diagnosis Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Immuno-oncology Diagnosis Market Size Market Share by Region (2018-2023)
Table 29. APAC Immuno-oncology Diagnosis Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Table 31. APAC Immuno-oncology Diagnosis Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Table 33. Europe Immuno-oncology Diagnosis Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Immuno-oncology Diagnosis Market Size Market Share by Country (2018-2023)
Table 35. Europe Immuno-oncology Diagnosis Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Table 37. Europe Immuno-oncology Diagnosis Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Immuno-oncology Diagnosis Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Immuno-oncology Diagnosis Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Immuno-oncology Diagnosis Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Immuno-oncology Diagnosis
Table 46. Key Market Challenges & Risks of Immuno-oncology Diagnosis
Table 47. Key Industry Trends of Immuno-oncology Diagnosis
Table 48. Global Immuno-oncology Diagnosis Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Immuno-oncology Diagnosis Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Immuno-oncology Diagnosis Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Immuno-oncology Diagnosis Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. 10x Genomics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 53. 10x Genomics Immuno-oncology Diagnosis Product Offered
Table 54. 10x Genomics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. 10x Genomics Main Business
Table 56. 10x Genomics Latest Developments
Table 57. Abbott Laboratories Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 58. Abbott Laboratories Immuno-oncology Diagnosis Product Offered
Table 59. Abbott Laboratories Main Business
Table 60. Abbott Laboratories Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Abbott Laboratories Latest Developments
Table 62. Abcam Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 63. Abcam Immuno-oncology Diagnosis Product Offered
Table 64. Abcam Main Business
Table 65. Abcam Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Abcam Latest Developments
Table 67. Adaptive Biotechnologies Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 68. Adaptive Biotechnologies Immuno-oncology Diagnosis Product Offered
Table 69. Adaptive Biotechnologies Main Business
Table 70. Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Adaptive Biotechnologies Latest Developments
Table 72. Aethlon Medical Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 73. Aethlon Medical Immuno-oncology Diagnosis Product Offered
Table 74. Aethlon Medical Main Business
Table 75. Aethlon Medical Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Aethlon Medical Latest Developments
Table 77. Agena Bioscience Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 78. Agena Bioscience Immuno-oncology Diagnosis Product Offered
Table 79. Agena Bioscience Main Business
Table 80. Agena Bioscience Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Agena Bioscience Latest Developments
Table 82. Angle plc Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 83. Angle plc Immuno-oncology Diagnosis Product Offered
Table 84. Angle plc Main Business
Table 85. Angle plc Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Angle plc Latest Developments
Table 87. Apocell Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 88. Apocell Immuno-oncology Diagnosis Product Offered
Table 89. Apocell Main Business
Table 90. Apocell Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Apocell Latest Developments
Table 92. ARUP Laboratories Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 93. ARUP Laboratories Immuno-oncology Diagnosis Product Offered
Table 94. ARUP Laboratories Main Business
Table 95. ARUP Laboratories Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. ARUP Laboratories Latest Developments
Table 97. Beckman Coulter Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 98. Beckman Coulter Immuno-oncology Diagnosis Product Offered
Table 99. Beckman Coulter Main Business
Table 100. Beckman Coulter Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Beckman Coulter Latest Developments
Table 102. Becton Dickinson Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 103. Becton Dickinson Immuno-oncology Diagnosis Product Offered
Table 104. Becton Dickinson Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Becton Dickinson Main Business
Table 106. Becton Dickinson Latest Developments
Table 107. Bioarray Genetics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 108. Bioarray Genetics Immuno-oncology Diagnosis Product Offered
Table 109. Bioarray Genetics Main Business
Table 110. Bioarray Genetics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Bioarray Genetics Latest Developments
Table 112. BioCartis Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 113. BioCartis Immuno-oncology Diagnosis Product Offered
Table 114. BioCartis Main Business
Table 115. BioCartis Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. BioCartis Latest Developments
Table 117. Biocept Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 118. Biocept Immuno-oncology Diagnosis Product Offered
Table 119. Biocept Main Business
Table 120. Biocept Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Biocept Latest Developments
Table 122. Biodesix Inc Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 123. Biodesix Inc Immuno-oncology Diagnosis Product Offered
Table 124. Biodesix Inc Main Business
Table 125. Biodesix Inc Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Biodesix Inc Latest Developments
Table 127. BioFluidica Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 128. BioFluidica Immuno-oncology Diagnosis Product Offered
Table 129. BioFluidica Main Business
Table 130. BioFluidica Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. BioFluidica Latest Developments
Table 132. BioGenex 40 bioM?rieux Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 133. BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Product Offered
Table 134. BioGenex 40 bioM?rieux Main Business
Table 135. BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. BioGenex 40 bioM?rieux Latest Developments
Table 137. Bio-Rad Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 138. Bio-Rad Immuno-oncology Diagnosis Product Offered
Table 139. Bio-Rad Main Business
Table 140. Bio-Rad Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Bio-Rad Latest Developments
Table 142. Bio-Techne Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 143. Bio-Techne Immuno-oncology Diagnosis Product Offered
Table 144. Bio-Techne Main Business
Table 145. Bio-Techne Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Bio-Techne Latest Developments
Table 147. Bristol-Myers Squibb Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 148. Bristol-Myers Squibb Immuno-oncology Diagnosis Product Offered
Table 149. Bristol-Myers Squibb Main Business
Table 150. Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. Bristol-Myers Squibb Latest Developments
Table 152. Cancer Genetics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 153. Cancer Genetics Immuno-oncology Diagnosis Product Offered
Table 154. Cancer Genetics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 155. Cancer Genetics Main Business
Table 156. Cancer Genetics Latest Developments
Table 157. Caris Molecular Diagnostics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 158. Caris Molecular Diagnostics Immuno-oncology Diagnosis Product Offered
Table 159. Caris Molecular Diagnostics Main Business
Table 160. Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 161. Caris Molecular Diagnostics Latest Developments
Table 162. CellMax Life Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 163. CellMax Life Immuno-oncology Diagnosis Product Offered
Table 164. CellMax Life Main Business
Table 165. CellMax Life Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 166. CellMax Life Latest Developments
Table 167. Charles River Laboratories Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 168. Charles River Laboratories Immuno-oncology Diagnosis Product Offered
Table 169. Charles River Laboratories Main Business
Table 170. Charles River Laboratories Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 171. Charles River Laboratories Latest Developments
Table 172. Chronix Biomedical Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 173. Chronix Biomedical Immuno-oncology Diagnosis Product Offered
Table 174. Chronix Biomedical Main Business
Table 175. Chronix Biomedical Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 176. Chronix Biomedical Latest Developments
Table 177. Circulogene Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 178. Circulogene Immuno-oncology Diagnosis Product Offered
Table 179. Circulogene Main Business
Table 180. Circulogene Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 181. Circulogene Latest Developments
Table 182. Clearbridge BioMedics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 183. Clearbridge BioMedics Immuno-oncology Diagnosis Product Offered
Table 184. Clearbridge BioMedics Main Business
Table 185. Clearbridge BioMedics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 186. Clearbridge BioMedics Latest Developments
Table 187. Clinical Genomics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 188. Clinical Genomics Immuno-oncology Diagnosis Product Offered
Table 189. Clinical Genomics Main Business
Table 190. Clinical Genomics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 191. Clinical Genomics Latest Developments
Table 192. Pfizer Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 193. Pfizer Immuno-oncology Diagnosis Product Offered
Table 194. Pfizer Main Business
Table 195. Pfizer Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 196. Pfizer Latest Developments
Table 197. Promega Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 198. Promega Immuno-oncology Diagnosis Product Offered
Table 199. Promega Main Business
Table 200. Promega Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 201. Promega Latest Developments
Table 202. Protagen Diagnostics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 203. Protagen Diagnostics Immuno-oncology Diagnosis Product Offered
Table 204. Protagen Diagnostics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 205. Protagen Diagnostics Main Business
Table 206. Protagen Diagnostics Latest Developments
Table 207. Qiagen Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 208. Qiagen Immuno-oncology Diagnosis Product Offered
Table 209. Qiagen Main Business
Table 210. Qiagen Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 211. Qiagen Latest Developments
Table 212. Quanterix Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 213. Quanterix Immuno-oncology Diagnosis Product Offered
Table 214. Quanterix Main Business
Table 215. Quanterix Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 216. Quanterix Latest Developments
Table 217. Rarecells SAS Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 218. Rarecells SAS Immuno-oncology Diagnosis Product Offered
Table 219. Rarecells SAS Main Business
Table 220. Rarecells SAS Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 221. Rarecells SAS Latest Developments
Table 222. Roche Diagnostics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 223. Roche Diagnostics Immuno-oncology Diagnosis Product Offered
Table 224. Roche Diagnostics Main Business
Table 225. Roche Diagnostics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 226. Roche Diagnostics Latest Developments
Table 227. Siemens Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 228. Siemens Immuno-oncology Diagnosis Product Offered
Table 229. Siemens Main Business
Table 230. Siemens Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 231. Siemens Latest Developments
Table 1. Immuno-oncology Diagnosis Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of PCR
Table 3. Major Players of NGS
Table 4. Major Players of Immunoassay
Table 5. Immuno-oncology Diagnosis Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Immuno-oncology Diagnosis Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Table 8. Immuno-oncology Diagnosis Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Immuno-oncology Diagnosis Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Table 11. Global Immuno-oncology Diagnosis Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Immuno-oncology Diagnosis Revenue Market Share by Player (2018-2023)
Table 13. Immuno-oncology Diagnosis Key Players Head office and Products Offered
Table 14. Immuno-oncology Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Immuno-oncology Diagnosis Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Immuno-oncology Diagnosis Market Size Market Share by Regions (2018-2023)
Table 19. Global Immuno-oncology Diagnosis Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Immuno-oncology Diagnosis Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Immuno-oncology Diagnosis Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Immuno-oncology Diagnosis Market Size Market Share by Country (2018-2023)
Table 23. Americas Immuno-oncology Diagnosis Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Table 25. Americas Immuno-oncology Diagnosis Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Table 27. APAC Immuno-oncology Diagnosis Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Immuno-oncology Diagnosis Market Size Market Share by Region (2018-2023)
Table 29. APAC Immuno-oncology Diagnosis Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Table 31. APAC Immuno-oncology Diagnosis Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Table 33. Europe Immuno-oncology Diagnosis Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Immuno-oncology Diagnosis Market Size Market Share by Country (2018-2023)
Table 35. Europe Immuno-oncology Diagnosis Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Table 37. Europe Immuno-oncology Diagnosis Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Immuno-oncology Diagnosis Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Immuno-oncology Diagnosis Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Immuno-oncology Diagnosis Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Immuno-oncology Diagnosis
Table 46. Key Market Challenges & Risks of Immuno-oncology Diagnosis
Table 47. Key Industry Trends of Immuno-oncology Diagnosis
Table 48. Global Immuno-oncology Diagnosis Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Immuno-oncology Diagnosis Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Immuno-oncology Diagnosis Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Immuno-oncology Diagnosis Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. 10x Genomics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 53. 10x Genomics Immuno-oncology Diagnosis Product Offered
Table 54. 10x Genomics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. 10x Genomics Main Business
Table 56. 10x Genomics Latest Developments
Table 57. Abbott Laboratories Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 58. Abbott Laboratories Immuno-oncology Diagnosis Product Offered
Table 59. Abbott Laboratories Main Business
Table 60. Abbott Laboratories Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Abbott Laboratories Latest Developments
Table 62. Abcam Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 63. Abcam Immuno-oncology Diagnosis Product Offered
Table 64. Abcam Main Business
Table 65. Abcam Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Abcam Latest Developments
Table 67. Adaptive Biotechnologies Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 68. Adaptive Biotechnologies Immuno-oncology Diagnosis Product Offered
Table 69. Adaptive Biotechnologies Main Business
Table 70. Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Adaptive Biotechnologies Latest Developments
Table 72. Aethlon Medical Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 73. Aethlon Medical Immuno-oncology Diagnosis Product Offered
Table 74. Aethlon Medical Main Business
Table 75. Aethlon Medical Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Aethlon Medical Latest Developments
Table 77. Agena Bioscience Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 78. Agena Bioscience Immuno-oncology Diagnosis Product Offered
Table 79. Agena Bioscience Main Business
Table 80. Agena Bioscience Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Agena Bioscience Latest Developments
Table 82. Angle plc Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 83. Angle plc Immuno-oncology Diagnosis Product Offered
Table 84. Angle plc Main Business
Table 85. Angle plc Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Angle plc Latest Developments
Table 87. Apocell Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 88. Apocell Immuno-oncology Diagnosis Product Offered
Table 89. Apocell Main Business
Table 90. Apocell Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Apocell Latest Developments
Table 92. ARUP Laboratories Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 93. ARUP Laboratories Immuno-oncology Diagnosis Product Offered
Table 94. ARUP Laboratories Main Business
Table 95. ARUP Laboratories Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. ARUP Laboratories Latest Developments
Table 97. Beckman Coulter Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 98. Beckman Coulter Immuno-oncology Diagnosis Product Offered
Table 99. Beckman Coulter Main Business
Table 100. Beckman Coulter Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Beckman Coulter Latest Developments
Table 102. Becton Dickinson Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 103. Becton Dickinson Immuno-oncology Diagnosis Product Offered
Table 104. Becton Dickinson Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Becton Dickinson Main Business
Table 106. Becton Dickinson Latest Developments
Table 107. Bioarray Genetics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 108. Bioarray Genetics Immuno-oncology Diagnosis Product Offered
Table 109. Bioarray Genetics Main Business
Table 110. Bioarray Genetics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Bioarray Genetics Latest Developments
Table 112. BioCartis Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 113. BioCartis Immuno-oncology Diagnosis Product Offered
Table 114. BioCartis Main Business
Table 115. BioCartis Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. BioCartis Latest Developments
Table 117. Biocept Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 118. Biocept Immuno-oncology Diagnosis Product Offered
Table 119. Biocept Main Business
Table 120. Biocept Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Biocept Latest Developments
Table 122. Biodesix Inc Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 123. Biodesix Inc Immuno-oncology Diagnosis Product Offered
Table 124. Biodesix Inc Main Business
Table 125. Biodesix Inc Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Biodesix Inc Latest Developments
Table 127. BioFluidica Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 128. BioFluidica Immuno-oncology Diagnosis Product Offered
Table 129. BioFluidica Main Business
Table 130. BioFluidica Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. BioFluidica Latest Developments
Table 132. BioGenex 40 bioM?rieux Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 133. BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Product Offered
Table 134. BioGenex 40 bioM?rieux Main Business
Table 135. BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. BioGenex 40 bioM?rieux Latest Developments
Table 137. Bio-Rad Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 138. Bio-Rad Immuno-oncology Diagnosis Product Offered
Table 139. Bio-Rad Main Business
Table 140. Bio-Rad Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Bio-Rad Latest Developments
Table 142. Bio-Techne Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 143. Bio-Techne Immuno-oncology Diagnosis Product Offered
Table 144. Bio-Techne Main Business
Table 145. Bio-Techne Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Bio-Techne Latest Developments
Table 147. Bristol-Myers Squibb Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 148. Bristol-Myers Squibb Immuno-oncology Diagnosis Product Offered
Table 149. Bristol-Myers Squibb Main Business
Table 150. Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. Bristol-Myers Squibb Latest Developments
Table 152. Cancer Genetics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 153. Cancer Genetics Immuno-oncology Diagnosis Product Offered
Table 154. Cancer Genetics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 155. Cancer Genetics Main Business
Table 156. Cancer Genetics Latest Developments
Table 157. Caris Molecular Diagnostics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 158. Caris Molecular Diagnostics Immuno-oncology Diagnosis Product Offered
Table 159. Caris Molecular Diagnostics Main Business
Table 160. Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 161. Caris Molecular Diagnostics Latest Developments
Table 162. CellMax Life Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 163. CellMax Life Immuno-oncology Diagnosis Product Offered
Table 164. CellMax Life Main Business
Table 165. CellMax Life Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 166. CellMax Life Latest Developments
Table 167. Charles River Laboratories Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 168. Charles River Laboratories Immuno-oncology Diagnosis Product Offered
Table 169. Charles River Laboratories Main Business
Table 170. Charles River Laboratories Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 171. Charles River Laboratories Latest Developments
Table 172. Chronix Biomedical Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 173. Chronix Biomedical Immuno-oncology Diagnosis Product Offered
Table 174. Chronix Biomedical Main Business
Table 175. Chronix Biomedical Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 176. Chronix Biomedical Latest Developments
Table 177. Circulogene Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 178. Circulogene Immuno-oncology Diagnosis Product Offered
Table 179. Circulogene Main Business
Table 180. Circulogene Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 181. Circulogene Latest Developments
Table 182. Clearbridge BioMedics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 183. Clearbridge BioMedics Immuno-oncology Diagnosis Product Offered
Table 184. Clearbridge BioMedics Main Business
Table 185. Clearbridge BioMedics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 186. Clearbridge BioMedics Latest Developments
Table 187. Clinical Genomics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 188. Clinical Genomics Immuno-oncology Diagnosis Product Offered
Table 189. Clinical Genomics Main Business
Table 190. Clinical Genomics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 191. Clinical Genomics Latest Developments
Table 192. Pfizer Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 193. Pfizer Immuno-oncology Diagnosis Product Offered
Table 194. Pfizer Main Business
Table 195. Pfizer Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 196. Pfizer Latest Developments
Table 197. Promega Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 198. Promega Immuno-oncology Diagnosis Product Offered
Table 199. Promega Main Business
Table 200. Promega Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 201. Promega Latest Developments
Table 202. Protagen Diagnostics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 203. Protagen Diagnostics Immuno-oncology Diagnosis Product Offered
Table 204. Protagen Diagnostics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 205. Protagen Diagnostics Main Business
Table 206. Protagen Diagnostics Latest Developments
Table 207. Qiagen Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 208. Qiagen Immuno-oncology Diagnosis Product Offered
Table 209. Qiagen Main Business
Table 210. Qiagen Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 211. Qiagen Latest Developments
Table 212. Quanterix Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 213. Quanterix Immuno-oncology Diagnosis Product Offered
Table 214. Quanterix Main Business
Table 215. Quanterix Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 216. Quanterix Latest Developments
Table 217. Rarecells SAS Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 218. Rarecells SAS Immuno-oncology Diagnosis Product Offered
Table 219. Rarecells SAS Main Business
Table 220. Rarecells SAS Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 221. Rarecells SAS Latest Developments
Table 222. Roche Diagnostics Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 223. Roche Diagnostics Immuno-oncology Diagnosis Product Offered
Table 224. Roche Diagnostics Main Business
Table 225. Roche Diagnostics Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 226. Roche Diagnostics Latest Developments
Table 227. Siemens Details, Company Type, Immuno-oncology Diagnosis Area Served and Its Competitors
Table 228. Siemens Immuno-oncology Diagnosis Product Offered
Table 229. Siemens Main Business
Table 230. Siemens Immuno-oncology Diagnosis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 231. Siemens Latest Developments
LIST OF FIGURES
Figure 1. Immuno-oncology Diagnosis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immuno-oncology Diagnosis Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Immuno-oncology Diagnosis Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Immuno-oncology Diagnosis Sales Market Share by Country/Region (2022)
Figure 8. Immuno-oncology Diagnosis Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Immuno-oncology Diagnosis Market Size Market Share by Type in 2022
Figure 10. Immuno-oncology Diagnosis in Research
Figure 11. Global Immuno-oncology Diagnosis Market: Research (2018-2023) & ($ Millions)
Figure 12. Immuno-oncology Diagnosis in Diagnostics
Figure 13. Global Immuno-oncology Diagnosis Market: Diagnostics (2018-2023) & ($ Millions)
Figure 14. Global Immuno-oncology Diagnosis Market Size Market Share by Application in 2022
Figure 15. Global Immuno-oncology Diagnosis Revenue Market Share by Player in 2022
Figure 16. Global Immuno-oncology Diagnosis Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Immuno-oncology Diagnosis Market Size 2018-2023 ($ Millions)
Figure 18. APAC Immuno-oncology Diagnosis Market Size 2018-2023 ($ Millions)
Figure 19. Europe Immuno-oncology Diagnosis Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Immuno-oncology Diagnosis Market Size 2018-2023 ($ Millions)
Figure 21. Americas Immuno-oncology Diagnosis Value Market Share by Country in 2022
Figure 22. United States Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Immuno-oncology Diagnosis Market Size Market Share by Region in 2022
Figure 27. APAC Immuno-oncology Diagnosis Market Size Market Share by Type in 2022
Figure 28. APAC Immuno-oncology Diagnosis Market Size Market Share by Application in 2022
Figure 29. China Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Immuno-oncology Diagnosis Market Size Market Share by Country in 2022
Figure 36. Europe Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Figure 37. Europe Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Figure 38. Germany Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 52. APAC Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 53. Europe Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 55. United States Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 56. Canada Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 59. China Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 60. Japan Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 61. Korea Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 63. India Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 64. Australia Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 65. Germany Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 66. France Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 67. UK Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 68. Italy Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 69. Russia Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 70. Spain Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 73. Israel Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 76. Global Immuno-oncology Diagnosis Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Immuno-oncology Diagnosis Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Immuno-oncology Diagnosis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immuno-oncology Diagnosis Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Immuno-oncology Diagnosis Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Immuno-oncology Diagnosis Sales Market Share by Country/Region (2022)
Figure 8. Immuno-oncology Diagnosis Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Immuno-oncology Diagnosis Market Size Market Share by Type in 2022
Figure 10. Immuno-oncology Diagnosis in Research
Figure 11. Global Immuno-oncology Diagnosis Market: Research (2018-2023) & ($ Millions)
Figure 12. Immuno-oncology Diagnosis in Diagnostics
Figure 13. Global Immuno-oncology Diagnosis Market: Diagnostics (2018-2023) & ($ Millions)
Figure 14. Global Immuno-oncology Diagnosis Market Size Market Share by Application in 2022
Figure 15. Global Immuno-oncology Diagnosis Revenue Market Share by Player in 2022
Figure 16. Global Immuno-oncology Diagnosis Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Immuno-oncology Diagnosis Market Size 2018-2023 ($ Millions)
Figure 18. APAC Immuno-oncology Diagnosis Market Size 2018-2023 ($ Millions)
Figure 19. Europe Immuno-oncology Diagnosis Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Immuno-oncology Diagnosis Market Size 2018-2023 ($ Millions)
Figure 21. Americas Immuno-oncology Diagnosis Value Market Share by Country in 2022
Figure 22. United States Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Immuno-oncology Diagnosis Market Size Market Share by Region in 2022
Figure 27. APAC Immuno-oncology Diagnosis Market Size Market Share by Type in 2022
Figure 28. APAC Immuno-oncology Diagnosis Market Size Market Share by Application in 2022
Figure 29. China Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Immuno-oncology Diagnosis Market Size Market Share by Country in 2022
Figure 36. Europe Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Figure 37. Europe Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Figure 38. Germany Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Immuno-oncology Diagnosis Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Immuno-oncology Diagnosis Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 52. APAC Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 53. Europe Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 55. United States Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 56. Canada Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 59. China Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 60. Japan Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 61. Korea Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 63. India Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 64. Australia Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 65. Germany Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 66. France Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 67. UK Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 68. Italy Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 69. Russia Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 70. Spain Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 73. Israel Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Immuno-oncology Diagnosis Market Size 2024-2029 ($ Millions)
Figure 76. Global Immuno-oncology Diagnosis Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Immuno-oncology Diagnosis Market Size Market Share Forecast by Application (2024-2029)
